Cargando…
39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome
OBJECTIVES/GOALS: Children with Down syndrome are at increased risk of respiratory diseases including asthma. Prenatal antibiotic exposure has been shown to be associated with the development of childhood asthma. We aim to estimate the association between prenatal antibiotic exposure and childhood a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129582/ http://dx.doi.org/10.1017/cts.2023.132 |
_version_ | 1785030776884035584 |
---|---|
author | Ammar, Lin Riddell, Corinne A. Ding, Tan Lee, Rees L. Maxwell-Horn, Angela Snyder, Brittney M. Gebretsadik, Tebeb Hartert, Tina V. Wu, Pingsheng |
author_facet | Ammar, Lin Riddell, Corinne A. Ding, Tan Lee, Rees L. Maxwell-Horn, Angela Snyder, Brittney M. Gebretsadik, Tebeb Hartert, Tina V. Wu, Pingsheng |
author_sort | Ammar, Lin |
collection | PubMed |
description | OBJECTIVES/GOALS: Children with Down syndrome are at increased risk of respiratory diseases including asthma. Prenatal antibiotic exposure has been shown to be associated with the development of childhood asthma. We aim to estimate the association between prenatal antibiotic exposure and childhood asthma among children with Down syndrome. METHODS/STUDY POPULATION: We conducted a retrospective cohort study of mother-child dyads of children with Down syndrome who were born 1995-2013. Both children and mothers were continuously enrolled in the Tennessee Medicaid Program (TennCare). Prenatal antibiotic exposure was measured using mother’s prescription fill records. Childhood asthma was defined between age 4.5-6 years by asthma-related healthcare encounters and asthma-specific medication fills. We assessed the association between prenatal antibiotic exposure and childhood asthma among children with Down syndrome using modified Poisson regression adjusting for maternal age, race, residence, education, marital status, smoking during pregnancy, maternal asthma status, delivery method, number of siblings, and children’s sex. RESULTS/ANTICIPATED RESULTS: Among 346 mother-child dyads of children with Down syndrome, 273 (78.9%) children were exposed prenatally to antibiotics and 104 (30.0%) had asthma by age 4.5-6 years. Among those who were exposed to at least one course, the median antibiotic course equaled 2 (interquartile range: 1-4). Prenatal antibiotic exposure was associated with a 20% increase in risk of childhood asthma in the unadjusted analysis (risk ratio [RR] 1.20, 95% confidence interval [CI] 0.78, 1.83) and a 26% increase in risk after adjustment (adjusted RR 1.26, 95% CI 0.79, 2.01). DISCUSSION/SIGNIFICANCE: In our study population, the majority of children with Down syndrome were exposed to antibiotics prenatally and the prevalence of asthma was high. Prenatal antibiotic exposure was associated with an increased risk of childhood asthma among children with Down syndrome; however, this increase was not statistically significant. |
format | Online Article Text |
id | pubmed-10129582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101295822023-04-26 39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome Ammar, Lin Riddell, Corinne A. Ding, Tan Lee, Rees L. Maxwell-Horn, Angela Snyder, Brittney M. Gebretsadik, Tebeb Hartert, Tina V. Wu, Pingsheng J Clin Transl Sci Biostatistics, Epidemiology, and Research Design OBJECTIVES/GOALS: Children with Down syndrome are at increased risk of respiratory diseases including asthma. Prenatal antibiotic exposure has been shown to be associated with the development of childhood asthma. We aim to estimate the association between prenatal antibiotic exposure and childhood asthma among children with Down syndrome. METHODS/STUDY POPULATION: We conducted a retrospective cohort study of mother-child dyads of children with Down syndrome who were born 1995-2013. Both children and mothers were continuously enrolled in the Tennessee Medicaid Program (TennCare). Prenatal antibiotic exposure was measured using mother’s prescription fill records. Childhood asthma was defined between age 4.5-6 years by asthma-related healthcare encounters and asthma-specific medication fills. We assessed the association between prenatal antibiotic exposure and childhood asthma among children with Down syndrome using modified Poisson regression adjusting for maternal age, race, residence, education, marital status, smoking during pregnancy, maternal asthma status, delivery method, number of siblings, and children’s sex. RESULTS/ANTICIPATED RESULTS: Among 346 mother-child dyads of children with Down syndrome, 273 (78.9%) children were exposed prenatally to antibiotics and 104 (30.0%) had asthma by age 4.5-6 years. Among those who were exposed to at least one course, the median antibiotic course equaled 2 (interquartile range: 1-4). Prenatal antibiotic exposure was associated with a 20% increase in risk of childhood asthma in the unadjusted analysis (risk ratio [RR] 1.20, 95% confidence interval [CI] 0.78, 1.83) and a 26% increase in risk after adjustment (adjusted RR 1.26, 95% CI 0.79, 2.01). DISCUSSION/SIGNIFICANCE: In our study population, the majority of children with Down syndrome were exposed to antibiotics prenatally and the prevalence of asthma was high. Prenatal antibiotic exposure was associated with an increased risk of childhood asthma among children with Down syndrome; however, this increase was not statistically significant. Cambridge University Press 2023-04-24 /pmc/articles/PMC10129582/ http://dx.doi.org/10.1017/cts.2023.132 Text en © The Association for Clinical and Translational Science 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. |
spellingShingle | Biostatistics, Epidemiology, and Research Design Ammar, Lin Riddell, Corinne A. Ding, Tan Lee, Rees L. Maxwell-Horn, Angela Snyder, Brittney M. Gebretsadik, Tebeb Hartert, Tina V. Wu, Pingsheng 39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome |
title | 39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome |
title_full | 39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome |
title_fullStr | 39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome |
title_full_unstemmed | 39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome |
title_short | 39 Prenatal antibiotic exposure and risk of childhood asthma among children with Down syndrome |
title_sort | 39 prenatal antibiotic exposure and risk of childhood asthma among children with down syndrome |
topic | Biostatistics, Epidemiology, and Research Design |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129582/ http://dx.doi.org/10.1017/cts.2023.132 |
work_keys_str_mv | AT ammarlin 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT riddellcorinnea 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT dingtan 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT leereesl 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT maxwellhornangela 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT snyderbrittneym 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT gebretsadiktebeb 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT harterttinav 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome AT wupingsheng 39prenatalantibioticexposureandriskofchildhoodasthmaamongchildrenwithdownsyndrome |